Add to ORKGA global computable general equilibrium model is used to examine how adoption of genetically modified (GM) biotechnology affects the welfare of interest groups within the United States and the European Union in the absence of policy responses to this technology and in their presence. Results indicate that changes in real income of producers can help explain differing GM policies in these two regions
There are major differences in biotechnology regulation among various countries and in particular be...
Current technological advances have been present in all aspects of human life, including technologic...
Reprinted as Ch. 17 in The WTO and Technical Barriers to Trade, edited by S. Henson and J.S. Wilson,...
A global computable general equilibrium model is used to examine how adoption of genetically modifie...
The development of genetically modified (GM) agricultural products requires new policies to manage p...
The development of genetically modified (GM) agricultural products requires new policies to manage p...
Over the past decade, the United States (US) and the European Union (EU) have implemented widely div...
The genetically modified organisms (GMOs) global policy landscape shows one of divergence not conver...
Biotechnology in regards to agriculture is complex and cannot be judged by a single factor. Exporter...
This paper analyses the impact of adopting or rejecting genetically modified (GM) crops in the Europ...
The debate about the use of genetically modified organisms (GMOs) in agricultural production continu...
This paper analyses the impact of adopting or rejecting genetically modified GM crops in the EU, tak...
The new agricultural biotechnologies that are generating genetically modified organisms (GMOs) are s...
The United States (US) exports more than US$6 billion in agricultural commodities to the European Un...
The economic welfare implications of some countries using new genetically modified varieties in crop...
There are major differences in biotechnology regulation among various countries and in particular be...
Current technological advances have been present in all aspects of human life, including technologic...
Reprinted as Ch. 17 in The WTO and Technical Barriers to Trade, edited by S. Henson and J.S. Wilson,...
A global computable general equilibrium model is used to examine how adoption of genetically modifie...
The development of genetically modified (GM) agricultural products requires new policies to manage p...
The development of genetically modified (GM) agricultural products requires new policies to manage p...
Over the past decade, the United States (US) and the European Union (EU) have implemented widely div...
The genetically modified organisms (GMOs) global policy landscape shows one of divergence not conver...
Biotechnology in regards to agriculture is complex and cannot be judged by a single factor. Exporter...
This paper analyses the impact of adopting or rejecting genetically modified (GM) crops in the Europ...
The debate about the use of genetically modified organisms (GMOs) in agricultural production continu...
This paper analyses the impact of adopting or rejecting genetically modified GM crops in the EU, tak...
The new agricultural biotechnologies that are generating genetically modified organisms (GMOs) are s...
The United States (US) exports more than US$6 billion in agricultural commodities to the European Un...
The economic welfare implications of some countries using new genetically modified varieties in crop...
There are major differences in biotechnology regulation among various countries and in particular be...
Current technological advances have been present in all aspects of human life, including technologic...
Reprinted as Ch. 17 in The WTO and Technical Barriers to Trade, edited by S. Henson and J.S. Wilson,...